Meld | $7,000,000 | (Jan 15, 2026)
Musical AI | $4,500,000 | (Jan 15, 2026)
Harmattan AI | $200,000,000 | (Jan 15, 2026)
Certified by Founder
Lodge
Artax Biopharma Inc
start up
United States
- Cambridge, MA
- 07/08/2024
- Unknown
- $8,000,000
Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T cell activation. Specific control over T cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.
- Industry Biotechnology Research
- Website https://artaxbiopharma.com/
- LinkedIn https://www.linkedin.com/company/artaxbiopharma/
Aikido Security | $60,000,000 | (Jan 15, 2026)
Tive | $20,000,000 | (Jan 15, 2026)
IO River | $20,000,000 | (Jan 15, 2026)
Flip (US) | $20,000,000 | (Jan 15, 2026)
Atomic Insights | $10,000,000 | (Jan 15, 2026)
osapiens | $100,000,000 | (Jan 15, 2026)
MeetCaria | $1,000,000 | (Jan 15, 2026)
SkyFi | $12,700,000 | (Jan 15, 2026)
Axol Bioscience Ltd. | $28,000,000 | (Jan 15, 2026)